Hyperaldosteronism (benign or malignant)
Hyperaldosteronism (benign or malignant) is rated under 38 CFR 38 CFR § 4.119, Diagnostic Code 7917, from 0% to 0% based on the frequency and functional severity of symptoms. The maximum 0% rating requires: Note: Evaluate as malignant or benign neoplasm, as appropriate.. Most claims establish the 0% or 0% rating before reaching the top tier.
What are the VA rating criteria for Hyperaldosteronism (benign or malignant)?
Note: Evaluate as malignant or benign neoplasm, as appropriate.
Note: Cross-reference — see referenced criteria for rating tiers
“Note: Evaluate as malignant or benign neoplasm, as appropriate.”
Common Questions About Hyperaldosteronism (benign or malignant) VA Ratings
What is the VA rating range for Hyperaldosteronism (benign or malignant)?
The VA rates Hyperaldosteronism (benign or malignant) under Diagnostic Code 7917 at 0%. The minimum 0% rating requires: Note: Evaluate as malignant or benign neoplasm, as appropriate.. The maximum 0% rating requires: Note: Evaluate as malignant or benign neoplasm, as appropriate..
Which 38 CFR diagnostic code does the VA use for Hyperaldosteronism (benign or malignant)?
The VA rates Hyperaldosteronism (benign or malignant) under Diagnostic Code (DC) 7917, governed by 38 CFR 38 CFR § 4.119. The diagnostic code establishes the specific rating tiers and severity criteria the VA examiner applies.
Can Hyperaldosteronism (benign or malignant) qualify for TDIU (Total Disability Individual Unemployability)?
Veterans rated for Hyperaldosteronism (benign or malignant) may qualify for TDIU if the condition — alone or in combination with other service-connected disabilities — prevents substantially gainful employment. A single disability rated at 60% or higher (or multiple disabilities combining to 70%, with one at 40%) can support a TDIU claim under 38 CFR § 4.16.
What evidence do I need to establish service connection for Hyperaldosteronism (benign or malignant)?
Service connection for Hyperaldosteronism (benign or malignant) requires three elements: (1) a current diagnosis of the condition, (2) an in-service event, injury, or disease, and (3) a medical nexus linking the current diagnosis to that in-service occurrence. A nexus letter from a treating or independent medical examiner is the most reliable nexus evidence.
What is the C&P exam like for Hyperaldosteronism (benign or malignant)?
A Compensation & Pension (C&P) exam for Hyperaldosteronism (benign or malignant) uses a Disability Benefits Questionnaire (DBQ) specific to the body system involved. The examiner documents the frequency, severity, and functional impact of your symptoms. Bring all relevant treatment records and be prepared to describe your worst-day symptoms — the examiner rates your condition based on the full clinical picture, not a single visit.
Get a Personalized Rating Analysis
VeteranHQ evaluates your symptoms against the exact 38 CFR criteria, identifies secondary conditions, and shows what evidence you need to support a higher rating.
Discover Your Benefits